---
schema_version: "secwatch.filing_event.v1"
accession: "0001567264-26-000014"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2026-03-06T23:59:59+00:00"
generated_at: "2026-05-15T18:42:03.309431+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Nasdaq confirmed compliance with $1.00 minimum bid price after 10 consecutive business days (Feb 19–Mar 4, 2026).
- Prior deficiency notice issued June 2025; extension granted until June 1, 2026; matter now closed.
- Late-stage clinical biotech focused on intratumoral cancer therapies using proprietary non-covalent conjugation technology.

## SEC filing metadata
- accession: 0001567264-26-000014
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2026-03-06T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000014/0001567264-26-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000014/intensity-20260305.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001567264-26-000014
- JSON: https://secwatch.observer/filing/0001567264-26-000014.json
- Plain text: https://secwatch.observer/filing/0001567264-26-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.